(
out of
431
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Research North
Clinic 2D/E, BMT/Hematology
2000 Circle of Hope
Salt Lake City
,
UT
84112
Board Certification
|
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)
|
Patient Rating
Patients consistently describe Dr. Shah as knowledgeable, thorough, and very caring. He explains complex information in clear, understandable terms, listens attentively, and involves patients and their families in decision-making. Reviewers also note he is responsive, coordinates care well, and provides reassurance during difficult diagnoses and treatments. Many patients express strong trust and gratitude for his care and bedside manner.
Generated via Patient Reviews
4.9
/5
( out of
431 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Associate Professor (Clinical) |
|---|---|
| Academic Divisions |
Hematology & Hematologic Malignancies
|
| Board Certification |
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)
|
Education history
| Undergraduate | Biomedical Engineering - University of Michigan | B.S.E. |
|---|---|---|
| Graduate Training | Biomedical Engineering - University of Michigan | M.S.E. |
| Professional Medical | Osteopathic Medicine - Kirksville College of Osteopathic Medicine - AT Still University of Health Sciences | D.O. |
| Residency | Internal Medicine - Indiana University School of Medicine | Resident |
| Fellowship | Hematology-Oncology - Karmanos Cancer Institute - Wayne State University | Fellow |
Selected Publications
Journal Article
- Advani RH, Kelsey CR, Armand P, Bello CM, Benitez CM, Bond D, Chen W, Cherian S, Czader M, Dabaja B, Daly ME, Frosch Z, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Hoppe RT, Isufi I, Johnston PB, Kelly K, Kenkre VP, Kline J, Lynch RC, McConathy J, Morgan D, Niu A, Paul S, Rabinovitch R, Salavati A, Sano D, Shah H, Spinner M, Svoboda J, Winter JN, Yahalom J, Yang JC, Montgomery S, Stehman (2026). Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 24(2), 41-60.
- Ermann D, Vardell V, Zacholski E, Fegley A, Modi D, Fedak K, Sundaram S, Rajeeve S, Goyal G, Hatic H, Torka P, Ba Aqeel S, Borogovac A, MacDougall K, Kothari S, Kress A, Travers E, Chilakamarri N, Brem E, Ayyappan S, Sigmund A, Bond D, Fitzgerald L, Wagner C, Hu B, Stephens DM, Shah (2026). Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia,
- Abramson JS, Straus DJ, Bartlett NL, Burke JM, Lynch RC, Domingo Domenech E, Hess B, Schuster SR, Linhares Y, Gandhi M, Shah HR, Jurczak W, Re A, Hahn U, Prince HM, Guo W, Davis G, Ho L, Fanale M, Yasenchak CA, Lee H (2026). Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma. Blood, 147(15), 1713-1722.
- Falade AS, Redd R, Desai SH, Moskowitz AJ, Shah HR, Geyer S, Ganesan N, Chang T, Othman T, Shah GL, Nedved AN, Durani U, Ng LS, Baron K, Ong SY, Yoon K, Ansell SM, Iyengar S, Micallef IN, Stuver RN, Herrera AF, Mei M, Armand P, Merryman R (2026). Impact of Novel Therapies on the Efficacy of Post-Transplantation Brentuximab Vedotin Maintenance in Hodgkin Lymphoma. Blood advances,
- Baek G, Varma G, Yamshon S, van Besien HJ, Bartlett NL, Watkins MP, Shah HR, Baron K, Merryman RW, Falade AS, Svoboda J, Prischak S, D'Angelo CR, Lukowski JD, Advani RH, Yeung AH, Rosenberg MC, Voutsinas JM, Di M, Lynch RC, Poh C, Raghunathan V, Shadman M, Smith SD, Till BG, Ujjani CS, Diefenbach C, Gopal A (2026). Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin Lymphoma. Blood advances,
- Baron K, Anto E, Esther J, Vardell VA, Pappas L, Bock A, Ermann DA, Fitzgerald LA, Hu B, Shah H (2025). Comparison of Real-World Outcomes in Patients With Follicular Lymphoma Treated With BR Versus RCHOP-Like Regimens. Clinical lymphoma, myeloma & leukemia,
- Desai SH, Moskowitz AJ, Merryman RW, Shah HR, Pederson LD, Geyer S, Ganesan N, Chang T, Othman T, Falade AS, Shah GL, Durani U, Sumransub N, Ng LS, Baron K, Ong SY, Yoon K, Ansell SM, Armand P, Iyengar S, Micallef IN, Stuver RN, Herrera AF, Mei M (2025). PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma. Blood,
- Ermann DA, Vardell VA, Shah H, Fitzgerald L, Tao R, Gaffney DK, Stephens DM, Hu (2024). Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy. Clinical lymphoma, myeloma & leukemia, 24(2), 94-104.e6.
- Soumerai JD, Barrientos JC, Ahn IE, Coombs CC, Gladstone DE, Hoffmann MS, Kittai AS, Jacobs RW, Lipsky A, Patel K, Rhodes JM, Skarbnik AP, Thompson MC, Ermann DA, Reville PK, Shah HR, Brown JR, Stephens D (2024). Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL. Blood advances, 9(5), 1213-1229.
- Desai SH, Spinner MA, David K, Bachanova V, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Arai S, Chang C, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Murphy J, Ansell S, Jagadish D, Orellana-Noia V, Diefenbach C, Iyenger S, Rappazzo KC, Mishra R, Choi Y, Nowakowski GS, Advani RH, Micallef I (2023). Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma. American journal of hematology,
- Chavez JC, Foss FM, William BM, Brammer JE, Smith SM, Prica A, Zain JM, Tuscano JM, Shah H, Mehta-Shah N, Ramakrishnan Geethakumari PR, Wang BX, Zantinge S, Wang L, Zhang L, Boutrin A, Zhao W, Cheng L, Standifer N, Hewitt L, Enowtambong E, Shao W, Sharma S, Carlesso G, Moscow JA, Siu L (2023). Targeting the Inducible T-cell Costimulator (ICOS) in patients with Relapsed/Refractory T-Follicular Helper Phenotype Peripheral T-Cell and Angioimmunoblastic T-Cell Lymphoma. Clinical cancer research,
- Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney D (2023). Secondary malignancies in non-Hodgkin lymphoma survivors: 40¿years of follow-up assessed by treatment modality. Cancer medicine, 12(3), 2624-2636.
- Wagner CB, Boucher K, Nedved A, Micallef IN, Desai S, Hatic H, Goyal G, Zacholski E, Fegley A, Sigmund AM, Bond DA, Samuels C, Kamdar MK, Ba Aqeel S, Torka P, MacDougall K, Borogovac A, Rajeeve S, Sundaram S, Fedak K, Modi D, Travers E, Ayyappan S, Chilakamarri N, Brem EA, Ermann DA, Fitzgerald LA, Hu B, Stephens DM, Shah (2023). Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of realworld outcomes. Haematologica, 108(11), 3025-3032.
- Goyal G, Lau KW, Wang X, Davidoff AJ, Huntington SF, Jamy O, Calip G, Shah H, Stephens DM, Miksad R, Parikh RB, Takvorian S, Neparidze N, Seymour E (2023). The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021. JAMA network open, 6(6), e2316642.
- Desai SH, Spinner MA, Evens AM, Sykorova A, Bachanova V, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Chang C, Michalka J, Ansell SM, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Wagner-Johnston N, Arai S, Nowakowski GS, Mocikova H, Jagadeesh D, Blum KA, Diefenbach C, Iyengar S, Rappazzo KC, Baidoun F, Choi Y, Prochazka V, Advani RH, Micallef (2023). Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era. Blood advances, 7(23), 7295-7303.
- Shah H, Jang H, Singh P, Kosti J, Kin A, Alavi A, Ratanatharathorn V, Ayash L, Uberti J, Ramchandren R, Kim S, Deol (2022). Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents. Leukemia & lymphoma, 63(4), 813-820.
- Stephens DM, Huang Y, Ruppert AS, Walker JS, Canfield D, Cempre CB, Fu Q, Baker S, Hu B, Shah H, Vadeboncoeur R, Rogers KA, Bhat S, Jaglowski SM, Lockman H, Lapalombella R, Byrd JC, Woyach J (2022). Selinexor combined with ibrutinib demonstrates tolerability and safety in advanced B-cell malignancies: A phase I study. Clinical cancer research, 28(15), 3242-3247.
- Shah H, Jang H, Kim S, Halwani A (2022). A comprehensive SEER registry analysis of elderly patients with classical Hodgkin lymphoma based on treatment era and race. British journal of haematology, 200(5), 579-586.
- Rock CB, Chipman JJ, Parsons MW, Weil CR, Hutten RJ, Tao R, Tward JD, Shah HR, Hu B, Stephens DM, Gaffney D (2022). Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy. Advances in radiation oncology, 7(6), 101035.
- Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leukemia & lymphoma, 64(2), 1-8.
- Orellana-Noia VM, Reed D, McCook AA, Sen JM, Barlow CM, Malecek MK, Watkins MP, Kahl BS, Spinner MA, Advani R, Voorhees TJ, Snow A, Grover NS, Ayers AA, Romancik J, Liu Y, Huntington SF, Chavez JC, Saeed H, Lazaryan A, Raghunathan V, Spurgeon SE, Ollila TA, Del Prete C, Olszewski A, Ayers EC, Landsburg DJ, Echalier B, Lee J, Kamdar M, Caimi PF, Fu T, Liu J, David KA, Alharthy H, Law JY, Karmali R, Shah HR, Stephens DM, Major A, Rojek AE, Smith SM, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail MA, Hill BT, Barrett-Campbell O, Lansigan F, Switchenko JM, Cohen JB, Portell C (2021). Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood, 139, 413-423.
- Shah HR, Stephens D (2021). Is there a role for anti-CD20 antibodies in CLL?. Hematology. American Society of Hematology. Education Program, 2021(1), 68-75.
- Shah H, Stephens D, Seymour J, Maddocks (2021). Incorporating Novel Targeted and Immunotherapeutic Agents in Treatment of B-Cell Lymphomas. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 41, 1-18.
- Shah H, Kim S, Singh P, Alavi A, Ratanatharathorn V, Ayash L, Uberti J, Deol (2020). Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts. American journal of hematology, 95(2), 198-204.
- Vaishampayan U, Shah H, Asad MF, Shi D, Dickow B, Suisham S, Domina J, Cher ML, Samantray J, Aoun H (2020). Adrenal Metastases as Sanctuary Sites in Advanced Renal Cancer. Journal of kidney cancer and VHL, 7(4), 1-7.
- Shah H, Vaishampayan (2018). Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of Treatment. Targeted oncology, 13(6), 679-689.
- Shah H, Bradford C, Sayar (2015). Acute Promyelocytic Leukemia Presenting with Severe Marrow Fibrosis. Case reports in hematology, 2015, 826894.
Review
- Salem AE, Shah HR, Covington MF, Koppula BR, Fine GC, Wiggins RH, Hoffman JM, Morton K (2022). PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies. Cancers, 14(23),
Case Report
- Shah H, McPherson K, Mansour A, Ramirez-Santrich C, Nassiri M, Shahda (2016). Neuroendocrine Differentiation of a Primary BRAF Mutant Colon Cancer in a Patient With a History of Hairy Cell Leukemia. Clinical colorectal cancer, 15(4), e235-e239.
Letter
- Vardell VA, Ermann DA, Fitzgerald L, Shah H, Hu B, Stephens D (2024). T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments. American journal of hematology, 99(3), 494-496.
- Vardell VA, Ermann DA, Fitzgerald LA, Shah HR, Hu B, Stephens D (2023). Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia. American journal of hematology, 98(7), E172-E174.
- Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali (2023). Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. Journal of hematology & oncology, 16(1), 111.
- Shah H, Kim S, Klimecki S, Charlson K, Uberti J, Schiffer CA, Fiala MA, Seymour (2022). Racial disparities in time to hematopoietic cell transplant among patients with hematologic malignancies at a large urban academic center. Bone marrow transplantation, 57, 1213-1215.
Very caring and careful in his explanations to make sure all was understood
Very articulate, excellent empathy, listens and explains, very comforting, extremely knowledgeable
Dr. Shah was one of the reasons we decided to switch our treatment here, so needless to say we are very pleased with Dr. Shah.
Truly fortunate and grateful to have Dr. Shah as my oncologist. There are not enough words to express my gratitude and respect. I hold Dr. Shah in the highest of all regards!
I owe Dr Shah my life!
Dr. Shah is easy to talk to, makes sure complex concepts are understood by the patient and always checks my understanding before changing topics.
Dr. Harsh R Shah diagnosed my Extranodal MZL with pleural effusions in [DATE REMOVED] and provided treatment to put the cancer in remssion in [DATE REMOVED]. Dr. Shah is an outstanding doctor whose knowledge and patient care are the very best.
Dr. Shah is a wonderful person. And highly qualified.
Very good doctor, caring, intelligent and works well with me !
Dr Shah was knowledgable and curtious. His care was very good and he explained my illness in a way I could understand.
I really like how Dr Shah listens and addresses your needs.
The whole experience was very good
My cancer diagnosis has been terrifying. There is so much new information and so many decisions to be made. I am scared, but I am absolutely confident in one thing: Huntsman is the best place for me to be and Dr. Shah will work in my best interest. For this I am extremely grateful.
Dr. Shah is a warm caring person. Highly professional and able to explain to the patient the details of treatment in words that a lay person can understand.
very knowledgeable, I feel comfortable with what he suggests for me and my care. Explains things thoroughly.
Dr Harsh Shah is Great - he listens and we discuss things each time we meet.
Sr. Shah listens to my concerns and gives me answers in a way that I can understand. He also explains the good and bad things about my health in a way that I can understand. He is very caring and understanding.
extremely attentive, shares information, values patient feedback. I trust him completely
Excellent. Highly recommend him. [TRANSLATED]
Dr. Shah has always been very knowledgeable, very professional and very much concerned for his patients. I'm fortunate to have had Dr. Shah as my oncologist for nearly five years now.
Very knowledgeable and professional.
It has been a great experience to work with Dr. Shah. His interaction with me was very pleasant and helpful.
I am fortunate to be in the care of Dr Shah.
His a real good doctor.
Dr Shah is a great doctor and provides excellent patient care.
He was fine.
very human and caring professional
Dr Shah is helpful with me and managing my cancer needs. If there is something that I don't understand he takes the time to explain further so I am aware of what is going on.
Thank you Dr Shah for everything you do! Your kindness, honesty, communication, and compassion are very appreciated! We are very thankful to have you as our motherÕs provider. We will always remember the time you have taken, even while you were on vacation, to reach out and care for my mom. Thank you so very much!
Very caring and professional
Excellent, supportive, thorough care. I am in remission. All he said was spot on, I am so appreciative and grateful
An empathetic and wonderful human being
Trust him with my life! Great bedside manner!
Smart, precessional, answers questions. Remembers things about us. He's great!¿
Dr Shah is great.
excellent and caring. Makes everything very clear and understandable.
We are truly fortunate to have Dr. Shah in our community. Will forever be grateful for his care, knowledge, competency and commitment to a cure and care. THank you!
Clear straightforward communication style. Willing to share uncertainties about future treatment plans
Very understanding person, Dr. Easy to talk to and he takes time to listen and explain what is going on.
Dr. Shah is a very caring physician with a very good bedside manner.
Dr. Shah is amazing. I have trusted him with my life, and would again!
Dr. Shah took the time to listen to my symptoms, discuss treatment options and valued my feedback. He addressed all my concerns and gave me a predictable future
Caring, professional, unde
not only is he an knowledgeable, medical practitioner, but he's kind, personable and assures me that he's interested in my well-being
Dr. Shah was great. He discussed my past medical history and followed up on the next steps.
I found Dr Shah to be very caring, understanding and professional. Dr Shah listened to me and put me at ease.
Doctor shah was amazing and treated me so good and helped me get better.
He answered all of our questions, and didn't rush us. We told him of our we questions about the drug we were taking and the costs and he had his pharmacist meet with us to help with getting the drug affordable.
I thank Dr Shah for treating me with respect and assuring me of the future.
Dr. Shah took me seriously and gave me the time and attention I needed. I felt like I was getting the best advice possible.
Good at explaining my results
The first time I met Dr. Shah I immediately knew I was in good hands and I had complete confidence in his abilities to provide me with the most effective treatment plan.
Dr. Shah is terrific
Very caring understanding and explain everything in details very well
Dr. Shah has been amazing. He is very good at listening and explaining. You can tell he is really giving his all to help his patients!
Dr Shah seems to be a very caring Doctor, and a great listener. I felt very comfortable with him and my husband thinks we have a good Doctor taking care of me.
Love and respect for Dr. Shah. He cares so much about patients needs.
He listens and helps me understand my disease.
He explained information well, never seemed rush, very thorough, hes caring and brings comfort to the patient and their family. Very positive throughout the entire course of treatment, which brings hope and comfort.
Dr. Shah is very knowledgeable and explained my treatment plan very well.
Like all Dr.s he is very busy.
Dr. Shah is fantastic.
I felt he was very concerned with my condition, answered all my questions, explained everything that I was going to be going through. Very helpful
Havent seen Dr Shah for a few months
I am so very pleased to have Dr. Shah as my oncologist. I just had my first meeting with Dr. Shah where he discussed the type of cancer I have, and while the diagnosis is not something anyone would want to hear, I immediately felt very comfortable with him and very confident in his abilities. His recommended course of action is the best I could hope for under the circumstances. It is a reasonable approach and I am so fortunate to be under his care.
Very knowledgeable, conversant in terms I could understand, openly shared research information with me. Included home Physician in matters. Also included wife in all options.
Dr. Shah was warm and personable. He is knowledgeable and made me feel confident in his assessment and recommendations.
Outstanding at listening, not only to me but his entire team. Eveyone had a voice. It was very nice and reassuring.
He's terrific! Very thorough and compassionate.
Dr, Shah has been very good in all aspects of the care he has provided during my cancer battle for more than two years.
Very good trusting doctor. Good bedside manner. Understanding.
I appreciate Dr. Shah's knowledge and experience working with my disease and the many complications that I have that make me a very complex case.
He was so kind. He answered all of our questions in a way that we understood.
Very impressed with his knowledge and experience
Was very efficient and appropriate. The only questions he did not answer were the ones I forgot to ask
he is a warm and caring dr.
I did not see Dr. Shah. In past meetings, he was very good and helpful in every way.
Dr. Shah was personable, attentive, and knowledgable. I felt understood and comfortable trusting him with my care.
Dr Shah is a wonderful caring doctor!
Since August, 2020, when I was diagnosed with Non Gastric MALT Lymphoma, Dr. Shah has provided excellent advice, care and concern in treating the cancer.
Dr. Shah continues to be EXCELLENT in his attention and care. He is very knowledgeable and follows my situation very attentively, I am in the care of a caring and loving physician, and I feel it with every visit...
Outstanding Oncologist!
I am please beyond any and all expectations with all the treatments I have received at Huntsman since my condition was diagnosed
Both Dr. Patel and Dr. Shah are very articulate and very good at explaining the disease and the procedures involved.
Dr Shah is a very caring concerned doctor
I was impressed by the time and care I received.
Dr Shah is thoroughly familiar with the process and subject matter. Explained everything in great detail, listened with utmost care, taking copious notes. My wife and I feel we are in the most capable hands.
The N/P wes very thorough in explaining my diagnosis, and ensuring discussion, she was great
The physician was very helpful and took the time to first explain and then offer information and answered all my questions. He helped my to be able to ask questions.
Good
It shows when people like working at any place, and I've noticed that doctors, nurses and staff in general like working at Huntsman. Always a high degree of professionalism, from the doctors to the cafeteria staff. Dr Shah is always very kind and feels like he knows what he's doing. Highly skilled doctor. All his PAs are always very kind and thoughtful. Always a good experience.
I am kept informed of my health
We really like Dr Shah. Thanks!
Awesome Doctors. Love my Doctors here and study coordinator. Everyone is excellent at their job
So far I have been pleased with all aspects of my treatment
Dr. Shah is great. His care and concern are exemplary.
Dr. Shah has settled in and was awesome during my recent appointment. I was spoiled by Dr. Glen and was expecting a smoother transition.
Both Dr. Shah and the PA were very responsive to my questions and concerns. I left feeling very good about the plans we made moving forward.
Very satisfied so far
My doctor was awesome
The ratings in this section would have all been very good if I had taken it upon myself to ask more questions
good
I was giving bad news on blood test results will no directional guidance where to go next.
After Dr. Martha Glen's retirement, I was concerned about her replacement. Dr. Shah was exceptionally through and helpful. No one can replace Dr. Glen's "bedside" manner, but Dr. Shah was a pleasant surprise.
Jessica Coon is amazing, always.Great to meet Dr. Shah. very impressive.
She was wonderful!!
Explained pros and cons of doing a biopsy of two apparent enlarged lymph nodes.
Dr. Shah is the best. The staff he has assembled are also great.